IP Library Granted Patent US 7,220,491
Granted Patent B2
US 7,220,491 · App. 10/325,443 · Granted May 22, 2007

Lubricious coating for medical devices

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,220,491
App. No.
10/325,443
Granted
May 22, 2007
Kind
B2
Abstract

Medical devices having at least a portion thereof coated with a lubricious polymer are disclosed. The lubricious polymer can be, for instance, a hydrogel polymer, such as a quaternary amine acrylate polymer. To bond the lubricious polymer to the surface of the medical device, the medical device is first subjected to a solvent and a multi-functional monomer. The solvent causes the multi-functional monomer to become imbibed into the surface of the medical device. Thereafter, a polymer having lubricious properties is polymerized on the surface of the device. The multi-functional monomer reacts with the polymer coating securely affixing the polymer coating to the device.

Claims (52)

1. A process for applying a lubricious coating to a surface of a medical device comprising:

providing a medical device made from a polymer;

contacting a surface of the medical device with a solvent and a multi-functional monomer, the solvent causing the surface of the medical device to swell and/or partially dissolve allowing the multi-functional monomer to be imbibed into the surface of the medical device;

drying the surface of the medical device; and

providing and polymerizing a hydrogel polymer on the surface of the medical device, the hydrogel polymer reacting with the multi-functional monomer imbibed into the surface of the device to form a lubricious coating.

2. A process as defined in claim 1 , wherein the surface of the medical device is made from a thermoplastic or a thermoset polymer.

3. A process as defined in claim 1 , wherein the surface of the medical device is made from polyvinyl chloride.

4. A process as defined in claim 1 , wherein the solvent comprises dimethyl sulphoxide, acetone, methylethyl ketone, toluene, alcohol, or xylene.

5. A process as defined in claim 1 , wherein the surface of the medical device is further contacted with an initiator.

6. A process as defined in claim 5 , wherein the initiator comprises 1-hydroxycyclohexyl phenyl ketone, α-hydroxy-1, αdimethylacetophenone, benzoyl peroxide, azo-bis-isobutyro-nitrile, di-t-butyl peroxide, bromyl peroxide, cumyl peroxide, lauroyl peroxide, isopropyl percarbonate, methylethyl ketone peroxide, cyclohexane peroxide, t-butyihydroperoxide, di-t-amyl peroxide, dicumyl peroxide, t-butyl perbenzoate, a benzoin alkyl ether, a benzophenone, a acetophenone, a thioxanthone, benzyl 2-ethyl anthraquinone, methylbenzoyl formate, 2-hydroxy-2-methyl-1-phenyl propane-1-one, 2-hydroxy-4′-isopropyl-2-methyl propiophenone, e-hydroxy ketone, tet-remethyl thiuram monosulfide, an allyl diazonium salt, camphorquinone or4-(N,N-dimethylamino) benzoate.

7. A process as defined in claim 1 , wherein the multi-functional monomer and solvent are combined into a solution when contacting the surface of the medical device and wherein the multi-functional monomer cross-links the hydrogel polymer.

8. A process as defined in claim 1 , wherein the multi-functional monomer comprises:

methylene-bis-acrylamide, diethylene glycol diacrylate, ethylene glycol diacrylate, triethylene glycol-bis-methacrylate, ethylene glycol-bis-methacrylate, ethylene glycol-dimethacrylate, bisacrylamide, triethyleneglycol-bis-acrylate, 3,3′-ethylidene-bis (N-vinyl-2-Pyrrolidone), trimethylolpropate trimethacrylate, glycerol trimethacrylate or polyethylene glycol dimethacrylate.

9. A process as defined in claim 1 , wherein the hydrogel polymer comprises:

wherein n is an integer of 2 to 3; R′, R″and R″′ are independently selected from the group consisting of H,C 1 to C 16 alkyl, aryl, arylamine, alkylamine, alkaryl and aralkyl; X is selected from the group consisting of O and NH; and Y − is an acceptable anionic counterion to the N + of the quaternary amine.

10. A process as defined in claim 1 , wherein the hydrogel polymer is polymerized by: contacting the surface of the medical device with a monomer comprising:

wherein R′, R″and R″′ are independently selected from the group consisting of H,C 1 to C 16 alkyl, aryl, arylamine, alkylamine, alkaryl and aralkyl; X is selected from the group consisting of O and NH; Y is an acceptable anionic counterion to the N + of the quaternary amine; m is an integer greater than 50,000;

and thereafter initiating polymerization.

11. A process as defined in claim 10 , whereas polymerization is initiated by exposing the surface of the medical device with ultraviolet light.

12. A process as defined in claim 1 , whereas a medical device is a tracheal suction device, a catheter, a guidewire, a stylet, an introducer, an enternal feeding device, or an endotracheal tube.

13. A process as defined in claim 1 , wherein the surface of the medical device comprises a silicone or a urethane.

14. A process as defined in claim 1 , wherein the hydrogel polymer is made from a monomer comprising an acryloyloxyalkyl-trialkyl-substituted amonimum salt, an acryloloxyalchyl-aryl-substituted ammonium salt, an acrylamidioalkyl-trialkyl-substituted ammonium salt, or an acrylamedoalkyl-aryl-substituted ammonium salt.

15. A process as defined in claim 1 , wherein the hydrogel polymer is made from a monomer comprising acryloyloxyethyltrimethyl ammonium chloride, or acryloyloxyethyltrimethyl ammonium methyl sulfate.

16. A medical device comprising:

a surface configured to move in relation to an adjacent surface; and

a lubricious coating applied to the surface, the lubricious coating comprising a quaternary amine acrylate polymer that has been cross-linked by a multi-functional monomer, the multi-functional monomer having been imbibed into the surface of the medical device.

17. A medical device as defined in claim 16 , wherein the surface of the device is made from a thermoplastic or a thermoset.

18. A medical device as defined in claim 16 , wherein the surface of the device is made from polyvinyl chloride.

19. A medical device as defined in claim 16 , wherein the multi-functional monomer comprises:

methylene-bis-acrylamide, diethylene glycol diacrylate, ethylene glycol diacrylate, triethylene glycol-bis-methacrylate, ethylene glycol-bis-methacrylate, ethylene glycol-dimethacrylate, bisacrylamide, triethyleneglycol-bis-acrylate, 3,3′-ethylidene-bis (N-vinyl-2-Pyrrolidone), trimethylolpropate trimethacrylate, or polyethylene glycol dimethacrylate.

20. A medical device as defined in claim 16 , wherein the quaternary amine acrylate polymer comprises:

wherein n is an integer of 2 to 3; R′, R″ and R″′ are independently selected from the group consisting of H,C 1 to C 16 alkyl, aryl, arylamine, alkylamine, alkaryl and aralkyl; X is selected from the group consisting of O and NH; and Y − is an acceptable anionic counterion to the N + of the quaternary amine.

21. A medical device as defined in claim 16 , wherein the medical device comprises tracheal suction device, a catheter, a guidewire, a stylet, an enteral feeding device, an introducer, or an endotracheal tube.

22. A medical device as defined in claim 16 , wherein the surface of the device is made from a silicone or a urethane.

23. A medical device as defined in claim 16 , wherein the quaternary amine acrylate polymer comprises acryloyloxyalkyl-trialkyl-substituted amonimum salt, an acryloyloxyalkyl-aryl-substituted ammonium salt, an acrylamidioalkyl-trialkyl-substituted ammonium salt, or an acrylamedoalkyl-aryl-substituted ammonium salt.

24. A medical device as defined in claim 16 , wherein the quaternary amine acrylate polymer comprises acryloyloxyethyltrimethyl ammonium chloride, or acryloyloxyethyltrimethyl ammonium methyl sulfate.

25. A process for applying a lubricious coating to the surface of a medical device comprising:

providing a medical device having a surface comprising polyvinyl chloride;

contacting the surface of the medical device with a solvent, an initiator, and a multi-functional monomer, the solvent causing the surface of the medical device to swell and/or partially dissolve allowing the multi-functional monomer to be imbibed into the surface of the medical device;

drying the surface of the medical device;

thereafter contacting the surface of the medical device with a monomer comprising:

wherein R′, R″ and R″′ are independently selected from the group consisting of H,C 1 to C 16 alkyl, aryl, arylamine, alkylamine, alkaryl and aralkyl; X is selected from the group consisting of O and NH; Y − is an acceptable anionic counterion to the N + of the quaternary amine; m is an integer greater than 50,000;

thereafter initiating polymerization;

polymerizing the monomer by exposing the monomer to ultraviolet light, the monomer polymerizing and forming a lubricious coating attached to the medical device.

26. A process as defined in claim 25 , wherein the solvent causes the surface of the medical device to swell.

27. A process as defined in claim 25 , wherein the solvent causes the surface of the medical device to partially dissolve.

28. A process as defined in claim 25 , wherein the solvent comprises dimethyl sulphoxide, acetone, methylethyl ketone, toluene, alcohol, or xylene.

29. A process as defined in claim 25 , wherein the multi-functional monomer comprises methylene-bis-acrylamide, diethylene glycol diacrylate, ethylene glycol diacrylate, triethylene glycol-bis-methacrylate, ethylene glycol-bis-methacrylate, ethylene glycol-dimethacrylate, bisacrylamide, triethyleneglycol-bis-acrylate, 3,3′-ethylidene-bis (N-vinyl-2-Pyrrolidone), trimethylolpropate trimethacrylate, or polyethylene glycol dimethacrylate.

30. A process as defined in claim 25 , whereas a medical device is a tracheal suction device, a catheter, a guidewire, a stylet, an introducer, an enteral feeding device, or an endotracheal tube.

31. A process as defined in claim 25 , wherein the hydrogel polymer is made from a monomer comprising an acryloyloxyalkyl-trialkyl-substituted amonimum salt, an acryloloxyalchyl-aryl-substituted ammonium salt, an acrylamidioalkyl-trialkyl-substituted ammonium salt, or an acrylamedoalkyl-aryl-substituted ammonium salt.

32. A process as defined in claim 25 , wherein the hydrogel polymer is made from a monomer comprising acryloyloxyethyltrimethyl ammonium chloride, or acryloyloxyethyltrimethyl ammonium methyl sulfate.

33. A process as defined in claim 25 , wherein the multi-functional monomer forms a mechanical bond with the surface of the medical device during the process.

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded Jan 6, 2026
From: JPMORGAN CHASE BANK, N.A.
To: O&M HALYARD, INC.; OWENS & MINOR DISTRIBUTION, INC.
Reel/Frame 074212/0570 →
RELEASE OF SECURITY INTEREST Recorded Jan 6, 2026
From: BANK OF AMERICA, N.A.
To: MEDICAL ACTION INDUSTRIES INC.; O&M HALYARD, INC.; OWENS & MINOR DISTRIBUTION, INC.
Reel/Frame 074203/0026 →
RELEASE OF SECURITY INTEREST Recorded Jun 30, 2022
From: CITIBANK, N.A.
To: AVENT, INC.; AVANOS MEDICAL SALES, LLC
Reel/Frame 060557/0062 →
PATENT SECURITY AGREEMENT Recorded Mar 29, 2022
From: O&M HALYARD, INC.; OWENS & MINOR DISTRIBUTION, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 059541/0024 →
PATENT SECURITY AGREEMENT Recorded Mar 12, 2021
From: MEDICAL ACTION INDUSTRIES INC.; OWENS & MINOR DISTRIBUTION, INC.; O&M HALYARD, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 055582/0407 →
RELEASE OF SECURITY INTEREST Recorded Mar 12, 2021
From: BANK OF AMERICA, N.A.
To: OWENS & MINOR DISTRIBUTION, INC.; MEDICAL ACTION INDUSTRIES, INC.; O&M HALYARD, INC.
Reel/Frame 055583/0722 →
INTELLECTUAL PROPERTY SECURITY INTEREST ASSIGNMENT AGREEMENT Recorded Jan 23, 2019
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: CITIBANK, N.A.
Reel/Frame 048173/0137 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2018
From: AVENT, INC.
To: O&M HALYARD, INC.
Reel/Frame 046324/0320 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded May 8, 2018
From: O&M HALYARD, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 046100/0646 →
RELEASE OF SECURITY INTEREST Recorded May 1, 2018
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: AVENT, INC.
Reel/Frame 046476/0710 →
SECURITY INTEREST Recorded Apr 6, 2015
From: AVENT, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 035375/0867 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2015
From: KIMBERLY-CLARK WORLDWIDE, INC.
To: AVENT, INC.
Reel/Frame 034754/0424 →